93. 原発性胆汁性胆管炎[原発性胆汁性肝硬変 (~2017.3)]
[臨床試験数:230,薬物数:215(DrugBank:51),標的遺伝子数:34,標的パスウェイ数:107

Searched query = "Primary biliary cholangitis", "Primary biliary cirrhosis", "PBC"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04604652
(ClinicalTrials.gov)
November 30, 202016/10/2020Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary CholangitisA Phase 2 Open Label, Proof of Concept Study of HTD1801 (BUDCA) in Adult Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to Standard Therapy - PRONTO-PBCPrimary Biliary Cholangitis;Primary Biliary Cirrhosis;Cholangitis;Cholestasis;Biliary Tract Diseases;Bile Duct StrictureDrug: HTD1801 (BUDCA)HighTide Biopharma Pty LtdNULLRecruiting18 Years75 YearsAll30Phase 2United States